Zhang et al. [21] showed that GPX4 activity was reduced in esophageal cancer TE1 cells after oridonin administration and was consistent with intracellular Fe2+, lipid peroxidation products, MDA, and ROS accumulation after oridonin. This evidence concerns the gene GPX4 and esophageal cancer.